Latest News and Press Releases
Want to stay updated on the latest news?
-
AUSTIN, TX, July 12, 2024 (GLOBE NEWSWIRE) -- Enovis™ (NYSE: ENOV), a leading innovator in shoulder arthroplasty systems that help improve quality of life and restore movement, introduced today the...
-
Wilmington, DE, May 10, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that its management team will participate...
-
Strong start to the year with sales growth of 27% on a reported basis and strong adjusted margin expansionReported first-quarter net loss from continuing operations of $1.32 per share with adjusted...
-
Wilmington, DE, April 17, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call...
-
Wilmington, DE, March 28, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV) ("Enovis" or the "Company"), an innovation-driven, medical technology growth company, today announced...
-
Continued strong momentum with fourth-quarter sales growth of 11%, organic growth of 8% Reported fourth-quarter net income from continuing operations of $0.05 per share with adjusted earnings per...
-
WILMINGTON, DE, Feb. 12, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology company, will showcase its latest technologies across the orthopedic care...
-
Wilmington, DE, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that Brady Shirley, President and COO,...
-
WILMINGTON, DE, Jan. 29, 2024 (GLOBE NEWSWIRE) -- Today, Enovis™ Corporation (NYSE: ENOV), an innovation-driven medical technology company, announced it will showcase the latest technologies from...
-
Wilmington, DE, Jan. 26, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call...